BL
CDLX icon

Bryan Lawrence’s Cardlytics CDLX Stock Holding History

Bryan Lawrence’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33,974
Closed -$7.58M – 10
2022
Q2 		$7.58M Buy
33,974
+3,500
+11% +$1.17M 5.59% 7
2022
Q1 		$16.8M Hold
30,474
– – 8.69% 7
2021
Q4 		$20.1M Buy
30,474
+3,329
+12% +$2.54M 9.2% 6
2021
Q3 		$22.8M Buy
27,145
+3,500
+15% +$3.55M 10.09% 5
2021
Q2 		$30M Hold
23,645
– – 12.93% 3
2021
Q1 		$25.9M Sell
23,645
-3,345
-12% -$4.42M 12.3% 3
2020
Q4 		$38.5M Sell
26,990
-6,295
-19% -$6.71M 15.3% 3
2020
Q3 		$23.5M Hold
33,285
– – 10.17% 5
2020
Q2 		$23.3M Hold
33,285
– – 12.38% 4
2020
Q1 		$11.6M Buy
33,285
+5,179
+18% +$3.67M 8.14% 7
2019
Q4 		$17.7M Hold
28,106
– – 10.54% 6
2019
Q3 		$9.42M Buy
+28,106
New +$9.01M 6.37% 8

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
ACM
Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
JCM
JS Capital Management New York $223M AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bryan Lawrence's CDLX Position: Q3 2022 in Review

Bryan Lawrence sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 33,974 shares — an estimated $7.58M sold.

Bryan Lawrence first reported a position in CDLX in Q3 2019 and held it in 12 quarters. The position peaked at $38.5M in Q4 2020. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Bryan Lawrence reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Bryan Lawrence sold 33,974 Cardlytics shares in Q3 2022, an estimated $7.58M.
  • Bryan Lawrence first reported a position in Cardlytics in Q3 2019 and held it in 12 quarters.
  • Bryan Lawrence's Cardlytics position peaked at $38.5M in Q4 2020.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Oakcliff Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.